Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2009 Dec 04;28449:33781-8. doi: 10.1074/jbc.M109.027516.
Show Gene links
Show Anatomy links
MAPK pathway activation delays G2/M progression by destabilizing Cdc25B.
Astuti P, Pike T, Widberg C, Payne E, Harding A, Hancock J, Gabrielli B.
???displayArticle.abstract???
Activation of the mitogen-activated protein kinase (MAPK) pathway by growth factors or phorbol esters during G(2) phase delays entry into mitosis; however, the role of the MAPK pathway during G(2)/M progression remains controversial. Here, we demonstrate that activation of the MAPK pathway with either epidermal growth factor or 12-O-tetradecanoylphorbol-13-acetate induces a G(2) phase delay independent of known G(2) phase checkpoint pathways but was specifically dependent on MAPK/extracellular signal-regulated kinase kinase (MEK1). Activation of MAPK signaling also blocked exit from a G(2) phase checkpoint arrest. Both the G(2) phase delay and blocked exit from the G(2) checkpoint arrest were mediated by the MEK1-dependent destabilization of the critical G(2)/M regulator cdc25B. Reintroduction of cdc25B overcame the MEK1-dependent G(2) phase delay. Thus, we have demonstrated a new function for MEK1 that controls G(2)/M progression by regulating the stability of cdc25B. This represents a novel mechanism by which factors that activate MAPK signaling can influence the timing of entry into mitosis, particularly exit from a G(2) phase checkpoint arrest.
Bansal,
Induction of Cdc25B regulates cell cycle resumption after genotoxic stress.
2007, Pubmed
Bansal,
Induction of Cdc25B regulates cell cycle resumption after genotoxic stress.
2007,
Pubmed Barboule,
Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition.
1999,
Pubmed Barth,
Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
1994,
Pubmed Barth,
Epidermal growth factor rapidly impairs activation of p34cdc2 protein kinase in HeLa cells at the G2-M boundary.
1995,
Pubmed Bélanger,
Mek2 is dispensable for mouse growth and development.
2003,
Pubmed
,
Xenbase Boutros,
The when and wheres of CDC25 phosphatases.
2006,
Pubmed Boutros,
CDC25 phosphatases in cancer cells: key players? Good targets?
2007,
Pubmed Bulavin,
p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony.
2002,
Pubmed Chun,
Phosphorylation of Cdc25C by pp90Rsk contributes to a G2 cell cycle arrest in Xenopus cycling egg extracts.
2005,
Pubmed
,
Xenbase Colanzi,
RAF1-activated MEK1 is found on the Golgi apparatus in late prophase and is required for Golgi complex fragmentation in mitosis.
2003,
Pubmed Dangi,
Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.
2006,
Pubmed Davies,
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
2000,
Pubmed De Boer,
Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.
2008,
Pubmed Dumesic,
Erk1/2 MAP kinases are required for epidermal G2/M progression.
2009,
Pubmed Edelmann,
Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-activated protein kinases in Swiss mouse 3T3 fibroblasts.
1996,
Pubmed El-Shemerly,
12-O-Tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells.
1997,
Pubmed Eymin,
p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation.
2006,
Pubmed Gabrielli,
Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells.
1996,
Pubmed Gabrielli,
Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis.
1997,
Pubmed Giroux,
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta.
1999,
Pubmed
,
Xenbase Goldstone,
Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR.
2001,
Pubmed Harding,
Subcellular localization determines MAP kinase signal output.
2005,
Pubmed Isoda,
The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest.
2009,
Pubmed
,
Xenbase Jazayeri,
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks.
2006,
Pubmed Kanemori,
Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.
2005,
Pubmed
,
Xenbase Klingler-Hoffmann,
Downregulation of protein phosphatase 2A activity in HeLa cells at the G2-mitosis transition and unscheduled reactivation induced by 12-O-tetradecanoyl phorbol-13-acetate (TPA).
2005,
Pubmed Kohn,
The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.
2003,
Pubmed Lavoie,
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.
1996,
Pubmed Lemaire,
CDC25B phosphorylation by p38 and MK-2.
2006,
Pubmed Lindqvist,
Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome.
2005,
Pubmed Liu,
The MAP kinase pathway is required for entry into mitosis and cell survival.
2004,
Pubmed Mailand,
Rapid destruction of human Cdc25A in response to DNA damage.
2000,
Pubmed Manke,
MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation.
2005,
Pubmed Mayor,
Interfering with MAP kinase docking interactions: implications and perspective for the p38 route.
2007,
Pubmed McKay,
Integrating signals from RTKs to ERK/MAPK.
2007,
Pubmed Nam,
The ERK-RSK1 activation by growth factors at G2 phase delays cell cycle progression and reduces mitotic aberrations.
2008,
Pubmed O'Connell,
The G2-phase DNA-damage checkpoint.
2000,
Pubmed Qiu,
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.
2000,
Pubmed Roberts,
Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis.
2002,
Pubmed Rossomando,
Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation.
1994,
Pubmed Schmitt,
CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage.
2006,
Pubmed Scholl,
Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
2009,
Pubmed Shinohara,
Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.
2006,
Pubmed Theis-Febvre,
Protein kinase CK2 regulates CDC25B phosphatase activity.
2003,
Pubmed Uto,
Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
2004,
Pubmed
,
Xenbase van Vugt,
Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells.
2004,
Pubmed Walter,
Activation of Wee1 by p42 MAPK in vitro and in cycling xenopus egg extracts.
2000,
Pubmed
,
Xenbase Widmann,
Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.
1999,
Pubmed Wright,
Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts.
1999,
Pubmed Xiao,
Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
2003,
Pubmed Yan,
BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
2005,
Pubmed
